J&J, Janssen Biotech Pegged with Antitrust Lawsuit Over Pricing of Blockbuster Drug Remicade
November 15, 2017 An antitrust lawsuit alleges Johnson & Johnson and Janssen Biotech rigged the pricing for Remicade, a 'blockbuster' drug used to treat Crohn's Disease.